Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:lovastatin
|
| gptkbp:approvalYear |
1987
|
| gptkbp:ATCCode |
C10AA02
|
| gptkbp:chemicalFormula |
C24H36O5
|
| gptkbp:contraindication |
pregnancy
active liver disease |
| gptkbp:drugClass |
statin
|
| gptkbp:eliminationHalfLife |
2-5 hours
|
| gptkbp:firstApprovedCountry |
gptkb:United_States
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:lovastatin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mevacor
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
HMG-CoA reductase inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
muscle pain
digestive problems liver enzyme abnormalities |
| gptkbp:usedFor |
lowering cholesterol
reducing risk of cardiovascular disease |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|